Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Konya Numune Hospital
This prospective observational study was performed on adult patients intubated and receiving MV for at least 48 hours in the 42-bed surgical and medical Intensive Care Unit. The study was conducted between August 2019 and January 2021 and approved by the Ethics Committee of Necmettin Erbakan University Medical School. Informed consents were obtained from patients participating in the study or from their relatives. The characteristics of patients with MDRO infection associated with different eGFR categories in VAP patients were recorded.
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients of 18 years of age and above
A clinical suspicion of VAP as defined in the American Thoracic Society (ATS) guidelines
A Clinical Pulmonary Infection Score (CPIS) \> 6
No signs and symptoms of infection at the time of admission to the ICU
You may not be if
Acute kidney injury
Renal replacement treatment (RRT)
Dialysis
Renal transplantation
Active tuberculosis
Malnutrition
Immunosuppression (neutropenia, HIV positivity, transplantation, prednisone treatment of ≥20 mg/day, etc.)
Any extrapulmonary infection other than VAP at the time of being included in the study
Respiratory cultures presented fungal agents
Normal flora
No growth
Clareo Health | The Relationship Between Renal Functions and Multi Drug Resistant Organisms
